Procept Biorobotics Q2 Revenue USD 94.498 Million Vs. IBES Estimate USD 92.9 Million
PRCT•Full-year outlook
- Outlook FY gross margin: 65%
- Outlook FY adjusted EBITDA: USD -35 to -30 million vs. IBES estimate of USD -25.5 million
Quarterly revenue and earnings
Aug. 4 (Reuters) - Procept Biorobotics Q2 net income was USD -26.861 million.
Q2 revenue was USD 94.498 million, compared with the IBES estimate of USD 92.9 million.
